Array BioPharma Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Array BioPharma Inc. with three other
pharmaceutical manufacturers in North America:
Peregrine Pharmaceuticals, Inc.
sales of $44.69 million
of which 99%
was Contract Manufacturing and Development o),
Natural Alternatives International, Inc.
of which 81%
was Private Label Contract Manufacturing), and
of which 100%
was Cancer Therapeutics).
Sales increased substantially in 2016:
Array BioPharma Inc. reported sales of $137.88 million
June of 2016.
increase of 165.6%
versus 2015, when the company's sales were $51.91 million.